Rezurock (belumosudil)

pCPA File Number: 22595
Negotiation Status:
Active Negotiation
Indication(s):
For the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy.
Sponsor/Manufacturer:
sanofi-aventis Canada Inc.
CDA-AMC Project Number:
SR0789-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable